Clinical trial
An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome
NCT00401258 · Mclean Hospital, Other · Completed
Key facts
| NCT number | NCT00401258 |
|---|---|
| Title | An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome |
| Official title | An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome Without Comorbid Major Depressive Disorder |
| Lead sponsor | Mclean Hospital, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | duloxetine |
| Enrollment | 15 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Nov 20, 2006 |
| Last update posted | Mar 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: